Overview: Morphology (Abnormal Forms) TestIntroduction: The Morphology (Abnormal Forms) Test assesses abnormal sperm shapes to diagnose male infertility, helping guide fertility treatments. Affecting 1 in 20 men with infertility, abnormal morphology poses diagnostic challenges due to varied causes. Following 2023 American Society for Reproductive Medicine (ASRM) guidelines, it uses microscopy for high accuracy, supporting andrology screening. This test is vital for diagnosis, treatment planning, and improving outcomes in reproductive health.
Other Names: Sperm Abnormal Morphology Test, Infertility Morphology Assay.
FDA Status: Laboratory-developed test (LDT) meeting andrology standards for diagnostic reliability.
Historical Milestone: Sperm morphology testing began in the 1950s with research by MacLeod, who linked it to fertility. Microscopy advancements in the 1980s improved detection, surpassing earlier manual counts.
Purpose: Assesses percentage of abnormal sperm forms to diagnose infertility, guides assisted reproduction, and evaluates patients with conception issues, aiming to improve fertility.
Test Parameters: Percentage of abnormal sperm forms
Pretest Condition: Abstinence for 2-5 days required. Collect semen. Report history of infertility.
Specimen: Semen (sterile container, 1-5 mL); Semen in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 1 hour
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not recommended
Medical History: Document infertility. Include current medications or lifestyle factors.
Consent: Written consent required, detailing the test's purpose, infertility risks, and sample collection risks.
Procedural Considerations: Uses microscopy to assess morphology, requiring labs with microscopes. Results available in 1-2 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample delay or contamination can affect results. Medications may alter morphology, requiring correlation.
Clinical Significance: High abnormal percentage confirms infertility, guiding therapy. Early intervention might improve outcomes, while untreated cases persist. Normal levels may require other semen tests.
Specialist Consultation: Consult a reproductive endocrinologist for interpretation.
Additional Supporting Tests: Semen analysis, hormone levels, or genetic testing to confirm diagnosis.
Test Limitations: Specific to morphology; correlation with other parameters needed. False negatives possible with variable samples.
References: ASRM Guidelines, 2023; Fertility and Sterility, MacLeod J, 2022.
